about
SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibitionMechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analysesCIS is a potent checkpoint in NK cell-mediated tumor immunity.Purification of SOCS (Suppressor of Cytokine Signaling) SH2 Domains for Structural and Functional Studies.JAK1 Takes a FERM Hold of Type II Cytokine Receptors.The molecular basis of JAK/STAT inhibition by SOCS1.Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosisEnzymatic Characterization of Wild-Type and Mutant Janus Kinase 1Negative regulation of RAF kinase activity by ATP is overcome by 14-3-3-induced dimerization
P50
Q27676669-CE088A43-E236-497C-A4B2-6947A5A6E930Q33857008-D5D9AEC3-A6C6-4E7B-A294-6C27D12B3499Q39744193-FE1DF3A5-5E6E-4DCC-9FA4-CAC2EBBF2BDAQ51188615-86EAC523-79C9-4775-B0C9-29B08982A51BQ51713635-0A5D1D5F-42DA-4C57-9201-527AA813B3E2Q54115189-C253CD67-E04A-4DF9-B05E-F0A737EE424DQ59332844-4E1BA44E-0A43-4585-8D6A-1A34181182BDQ91095526-F11EA620-78CC-4FF3-92C7-C70C2147A0DDQ92979635-1E9E3B61-6692-4784-BD16-57284A6A6EB2
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Nicholas P D Liau
@en
Nicholas P D Liau
@nl
type
label
Nicholas P D Liau
@en
Nicholas P D Liau
@nl
prefLabel
Nicholas P D Liau
@en
Nicholas P D Liau
@nl
P31
P496
0000-0002-3887-899X